I agree that this site is using cookies. You can find further informations here.
X
McGregor, Bradley A
173  results:
Search for persons X
?
1

Characterization of FOLH1 Expression in Renal Cell Carcinom:

Ovruchesky, Eric ; Pan, Elizabeth ; Guer, Melis...
Cancers.  16 (2024)  10 - p. 1855 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Randomized Phase II Study Evaluating the Addition of Pembro..:

Choudhury, Atish D. ; Kwak, Lucia ; Cheung, Alexander...
Cancer Immunology Research.  12 (2024)  6 - p. 704-718 , 2024
Link: https://doi.org/10.1158/..
 
?
3

Comprehensive multiplexed autoantibody profiling of patient..:

Ravi, Praful ; Freeman, Dory ; Thomas, Jonathan...
Journal for ImmunoTherapy of Cancer.  12 (2024)  2 - p. e008215 , 2024
Link: https://doi.org/10.1136/..
 
?
4

Association between neutrophil-to-eosinophil ratio and effi..:

Tucker, Matthew ; Chen, Yu-Wei ; Voss, Martin H...
BMJ Oncology.  3 (2024)  1 - p. e000181 , 2024
Link: https://doi.org/10.1136/..
 
?
5

Vascular endothelial growth factor-targeted therapy in pati..:

Albiges, Laurence ; McGregor, Bradley A. ; Heng, Daniel Y.C....
Cancer Treatment Reviews.  122 (2024)  - p. 102652 , 2024
Link: https://doi.org/10.1016/..
 
?
6

One Size Fits Some: Approaching Rare Malignancies of the Ur..:

Berg, Stephanie A ; McGregor, Bradley A
Current Treatment Options in Oncology.  , 2024
Link: https://doi.org/10.1007/..
 
?
7

Impact of renal cell carcinoma molecular subtypes on immuno..:

Saliby, Renée Maria ; Labaki, Chris ; Jammihal, Tejas R....
Cancer Cell.  42 (2024)  5 - p. 732-735 , 2024
Link: https://doi.org/10.1016/..
 
?
8

The Natural History of Renal-Cell Carcinoma with Sarcomatoi..:

Tully, Karl H. ; Berg, Sebastian ; Paciotti, Marco...
Clinical Genitourinary Cancer.  21 (2023)  1 - p. 63-68 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Subsequent Line Systemic Treatment Options for Advanced Ren..:

, In: Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma,
El Zarif, Talal ; Xu, Wenxin ; McGregor, Bradley A. - p. 293-308 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Circulating and intratumoral immune determinants of respons..:

Saliby, Renee Maria ; El Zarif, Talal ; Bakouny, Ziad...
The Oncologist.  28 (2023)  Supplement_1 - p. S15-S16 , 2023
Link: https://doi.org/10.1093/..
 
?
11

A Matching-adjusted Indirect Comparison of Nivolumab Plus C..:

McGregor, Bradley ; Geynisman, Daniel M. ; Burotto, Mauricio...
European Urology Oncology.  6 (2023)  3 - p. 339-348 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Zanzalintinib in combination with immune checkpoint inhibit..:

Motzer, Robert J ; Choueiri, Toni K ; Garmezy, Benjamin...
The Oncologist.  28 (2023)  Supplement_1 - p. S10-S11 , 2023
Link: https://doi.org/10.1093/..
 
?
13

Grade 3/4 Adverse Event Costs of Immuno-oncology Combinatio..:

McGregor, Bradley ; Geynisman, Daniel M ; Burotto, Mauricio...
The Oncologist.  28 (2023)  1 - p. 72-79 , 2023
Link: https://doi.org/10.1093/..
 
?
14

CABOSEQ: The Effectiveness of Cabozantinib in Patients With..:

Navani, Vishal ; Wells, J Connor ; Boyne, Devon J...
Clinical Genitourinary Cancer.  21 (2023)  1 - p. 106.e1-106.e8 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Cabozantinib Safety With Different Anticoagulants in Patien..:

Shayeb, Akram M. ; McManus, Hannah Dzimitrowicz ; Urman, Danielle...
Clinical Genitourinary Cancer.  21 (2023)  1 - p. 55-62 , 2023
Link: https://doi.org/10.1016/..
 
1-15